Member Info for crumbs

Chippers should just do a 2-minute anecdote about how Oasis never cracked America and CH should just do 1 minute of mumbling off cards JC has given him ...the other 2 hours should be given entirely over to LD and SC talking about science and trial design...

I think the cost of the combo trial is about �5 million... it may be in hardman somewhere... we know the trial was scaled down quite a lot (possibly an omen lol) from the original design but is still designed to get best possible conclusive data as cheaply as possible..I remember RG making a comment about this trial...'the one they all want to see' which I took as interested pharma want to see results before moving on SCIB1....swimmer chart obviously not convincing enough! However, I as an optimist for the science team of scancell if not so much the business team at the moment we can see things really hotting up in this immuno oncology market which means moves could be made at any moment... J&J on the look out for one now they find themselves with extra cash as will many others be.... so in that context us now not really 'needing' to do a deal yet does give us a strong hand .... until amazing results are in of course and still no deal/s! lol...

Well, shame the good news of the new platform got a little eclipsed by the other news, in time that should correct itself ... and there is still a potential other new platform coming from PTM too...maybe you will take up your OOs this time? .. I'll take mine and will nibble a few if the price does indeed drop below 12p... have to take an optimistic view and imagine JC is just greedily hoarding before signing off on a few of the waiting mega deals that keep landing on his desk but somehow keep slipping under it :)

From tweetosphere... I think McBlue has a valid point: unil Patel ‏ @Sunil_128 2h2 hours ago More Replying to @GlencrossJohn @scancellpharma Well said @GlencrossJohn 0 replies 0 retweets 0 likes Reply Retweet Like Dave Edward ‏ @Dave_Edward 3h3 hours ago More Replying to @GlencrossJohn @scancellpharma You beat me to it John! Looking forward to the answer. 😏 0 replies 0 retweets 0 likes Reply Retweet Like McBlue ‏ @McBlue1962 3h3 hours ago More Replying to @GlencrossJohn @scancellpharma UK fundings continue - Question then is, what need for a US based Executive Chairman and a San Diego office ? Tangible benefits remain illusive ! 0 replies 0 retweets 0 likes Reply Retweet Like Bryan Walker ‏ @bryanwalker88 3h3 hours ago More Replying to @GlencrossJohn @scancellpharma Especially on the same days as announcing the acquisition of a potential 3rd platform, which any other day would have driven a rise in the SP

John Glencross even... jeez ohn Glencross ‏ @GlencrossJohn 1h1 hour ago More I understand that after a week of strong road showing and a very good story, they were disappointed when the adviser told them where early pricing indications were. I feel it�s coming good - even very good - but it�s the capital markets side that has lagged. 0 replies 0 retweets 0 likes Reply Retweet Like End of conversation New conversation Millionsbytheminute ‏ @millionsbythe 55m55 minutes ago More Replying to @scancellpharma What happened to the states side push for finance? Or is that what you are referring to John? Frustrating to say the least but at least bits of the trial are funded now. One wonders if scancell will ever escape the ever present issue of funding at least at depressed valuations! 1 reply 0 retweets 0 likes Reply 1 Retweet Like John Glencross ‏ @GlencrossJohn 47m47 minutes ago More The US is a 2-3 year plan which is underway. They need to be known to US funders and they then need some more milestones and to have a larger cap. At the end of the day, data and progress on the drug candidates will determine things.

Bit of J Gilchrist insight on RG's tweet I like that he communicates with us ...we are all in the same boat after all seems he is still very confident but not best pleased at price JC is getting his shares at his ahem I mean market decided the placing should be at.... https://twitter.com/scancellpharma/status/986603570228232192

Of biotech lol...I was dreaming more Barcelona

Bit of LTH fatigue...Just as sp looks to getting at 20p (many averages) it's popped on us ...Sure can change fast plenty to look forward to here in fact for a newbie wanting to build a holding in minnow that has whale potential scancell is surely looking jammy :)

Yet to be revealed...Taking up their OO allowance would be quite a wedge

Who knows I personally have no trust in our BOD's timescales.. however seems we will get BioNtech news towards the end of year going off CH interview though again that could become end of next year lol... grand challenge though does seem to be November for sure!

probably more a case of he has mixed thoughts and feelings just like most of us who have invested here over the many years... hopefully he is chillaxing as it were because this could have been much worse funds are in and we do at least get that trial we have been waiting on forever going and have added some extra potentially very valuable tech to our pipeline....that we had seemingly had no choice but to raise it all at a dilutive 12p when we have been getting 'commercial' nods from RG and CH is a bit grating on the trust factor though.

He inherited it off RG :)...think this BOD owes us LTH 'supporters' and I do not think it is wise to p off calculus either... wonder did or could they even they partake on the placing or maybe they can on OO....

The SCIB1 combo trial elephant that was hanging around sat on sp is gone the trial will happen now....wether there is enough to cover modi 1 trial not clear yet...

Does seem 'near-term' monetization could mean waiting on full trial data coming in and hoping someone is biting by then which means about 2 years...

Not happy...J Glencross https://twitter.com/scancellpharma/status/986603570228232192 John Glencross ‏ @GlencrossJohn 18m18 minutes ago More Replying to @scancellpharma If it was oversubscribed, why was it necessary to have such a big discount? Quite!...is this all about new directors and mates getting in before the real fun begins

Needs a new telephone!

The doubt is gone SCIB1 trial is happening at long last... interesting they also say funds to begin modi 1 trial... if we get the full �8 million though not sure pi will cover �2 mill myself though I'll be doing my part:)... would a full �8 million cover both SCIB1 combo and modi 1 ?...so many questions for AGM lol

Could this tie in with that too... no pi invited to it... did some ii come forward wanting in

So much potential... be nice to hear from the BOD

Well BioNtech commercial action probably would not arrive till new year... meantime grand challenge though... that could least cover one modi product and a small proof of concept trial.. hmm still think Genentech will make a move for moditope post patent.. scancell - always suprises not always the ones you want when you want em but still the science never ever stops getting better.